Abstract
Patients with depression and cardiovascular disease must be monitored carefully during pharmacotherapy because their depressive symptoms and/or antidepressant medications may have a negative impact on heart function. Mirtazapine is considered a safe and effective antidepressant drug used in the treatment of cardiovascular and other systemic diseases. This report, however, documents a case of myocardial infarction that appeared to be associated with mirtazapine administration.
| Original language | English |
|---|---|
| Pages (from-to) | 45-46 |
| Number of pages | 2 |
| Journal | Clinical Psychopharmacology and Neuroscience |
| Volume | 4 |
| Issue number | 1 |
| Publication status | Published - 2006 Aug |
Keywords
- Depression
- Heart
- Mirtazapine
- Myocardial infarction
ASJC Scopus subject areas
- Psychiatry and Mental health
- Behavioral Neuroscience
- Pharmacology (medical)